title: Status epilepticus in epileptic patients. Related syndromes, precipitating factors, treatment and outcome in a video-EEG population-based study.
abstract: BACKGROUND
  Status epilepticus (SE) is frequently observed in epileptic patients. We reviewed a series of video-EEG documented SE to define the characteristics of SE in this population.
  
  
  METHODS
  Retrospective evaluation of 50 epileptic patients with SE, revision of the electro-clinical data and therapies, and definition of the semeiological subtypes, aetiology, outcome and related epileptic syndromes.
  
  
  RESULTS
  We identified 28 convulsive (19 focal and 9 generalized) and 22 non-convulsive (8 focal and 14 generalized) SE patients. In 13 patients, SE was situation-related (poor compliance, AED reduction, worsening seizures). In the remaining 37 patients, SE was related to the natural history of epilepsy (progression of underlying pathologies or intrinsic expression of epileptic syndromes); in these last cases, our results show a higher occurrence in cryptogenic frontal epilepsy (p=0.01). We identified two subgroups according to the duration of the event, i.e. SE lasting <12h and SE lasting >12h. Our results showed a worse response to therapy in SE lasting >12h (p=0.01), a better response to therapy in non-convulsive SE than in convulsive SE (p<0.05) and a relationship at statistical significance limit between a poor response to therapy/worse outcome and symptomatic epileptic syndromes (p=0.06).
  
  
  CONCLUSIONS
  SE in epileptic patients has a wide spectrum of electro-clinical features. It may be related to the withdrawal or reduction of AEDs, or may even be the expression of the evolution of epileptic syndromes. Response to therapy is dependent on early diagnosis and therapy.
authors.affiliation: Department of Neurological Sciences, Policlinico Umberto I degrees , University of Rome La Sapienza, Italy. c_dibonaventura@yahoo.it
authors.forename: C
authors.initials: C
authors.lastname: Di Bonaventura
authors.forename: F
authors.initials: F
authors.lastname: Mari
authors.forename: N
authors.initials: N
authors.lastname: Vanacore
authors.forename: J
authors.initials: J
authors.lastname: Fattouch
authors.forename: A
authors.initials: A
authors.lastname: Zarabla
authors.forename: A
authors.initials: A
authors.lastname: Berardelli
authors.forename: M
authors.initials: M
authors.lastname: Manfredi
authors.forename: M
authors.initials: M
authors.lastname: Prencipe
authors.forename: A T
authors.initials: AT
authors.lastname: Giallonardo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D018672:Community Health Planning; D004569:Electroencephalography / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013226:Status Epilepticus / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology; D016896:Treatment Outcome; D014741:Video Recording / Q000379:methods
chemical_list: D000927:Anticonvulsants